AzTrials
AzTrials

Suicide PreventionCo-crea K&JNCT06776328

Co-creation of Tools for Children and Adolescents with Suicidal Thoughts And/or Behaviour

A study testing Tools in people with Suicide Prevention and Suicidal Ideation, run by University Ghent at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Evidence shows that there are very few evidence-based tools or interventions specifically targeting suicidality in children and adolescents. It is crucial to address suicidal thoughts in these populations, as research indicates that discussing suicidality does not increase suicidal behavior but may instead reduce the… Read more about this study

Who is it for?
Ages 10 to 18 years
What is being tested?
Tools
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteBelgium
Study dates
12 Dec 2024to 1 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Aged 10-18 years
  • Proficient in Dutch
  • Has experienced suicidal thoughts in the past

Who cannot join

  • Limited cognitive ability
  • Currently experiencing an acute suicidal crisis

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Eva De Jaegere, PhD contact

+32 9 332.07.75

eva.dejaegere@ugent.be

Belgium1 site, 1 recruiting
  • Flemish Centre of Expertise in Suicide Prevention, Ghent University

    Ghent, 9000

    Eva De Jaegere, PhD, +32 9 332.07.75, eva.dejaegere@ugent.be

    Recruiting

Other trials in Belgium

About this study

Evidence shows that there are very few evidence-based tools or interventions specifically targeting suicidality in children and adolescents. It is crucial to address suicidal thoughts in these populations, as research indicates that discussing suicidality does not increase suicidal behavior but may instead reduce the associated risk. Furthermore, the field of suicide prevention increasingly incorporates digital technologies. Studies suggest that digital interventions targeting suicidality in young people show promise in enhancing knowledge, regulating emotions, developing coping skills, and managing suicidal thoughts and behaviors.

As part of this project, we will develop the following practical tools:

Read more
  • A creative methodology for professionals to engage children and adolescents in talking about their suicidal thoughts.
  • A self-help app for suicidal young people and their support networks. The development process will involve co-creation, with input from children and adolescents playing a central role.

A total of 30 children and adolescents aged 10 to 18 years, who have experienced suicidal thoughts in the past, will participate in this project. The co-creation sessions will be conducted in groups of up to 10 participants. Participants can attend a minimum of 1 and a maximum of 10 sessions, each lasting up to 1.5 hours. The sessions will be facilitated by researchers from VLESP and will take place at a location convenient for participants or in Ghent (the primary location of the research team). If preferred by participants, one or more sessions may also be held online.

For participants who do not wish to join a group, individual sessions can be arranged. Each session will be attended by two researchers, with the potential involvement of professionals specializing in tool development. Several potential developers will be invited to submit proposals for creating the tools, and the selection of the developer will be based on these submissions.

During the sessions, participants will review and evaluate various prototypes of the app. However, the prototypes will not be tested for effectiveness by the young participants.

Being tested
Tools
Keywords
co-creation, participatory research, children, adolescents, suicide prevention, suicidal ideation, suicidal behaviour, suicide
Medical subject headings
Suicide Prevention, Suicidal Ideation, Suicide

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ToolsOther

    In the co-creation meetings, developed tools will be presented. Participants will be asked to provide feedback and input to tailor these tools to the needs and preferences of children and adolescents with suicidal thoughts/behavior.

Study groups in NCT06776328
Study groupRoleWhat they receive
Co-creation meetingsOtherAll participants will be invited to participate in the co-creation meetings.
Receives: Other: Tools

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Co-creation questions

    In the co-creation sessions, participants will be asked about:

    • Current app usage
    • Preferences and needs regarding an app/creative methodology
    • Accessibility and usability of the tools
    • Privacy and confidentiality
    • Social support and community engagement
    • Sensitivity and language
    • Seeking help and professional support
    • Sustained engagement
    • Feedback on tool prototypes
    • Reflections on how they experienced the session

    Measured: From enrolment to end of co-creation sessions (10 sessions of 1.5 hours max over the course of the study)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2025
  2. Study start12 Dec 2024
  3. Primary completion1 Apr 2026 (estimated)
  4. Study completion1 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06776328
Sponsor's protocol ID
ONZ-2024-0211
Other IDs
GE0-1GDF2JA
Acronym
Co-crea K&J
Status last verified
Jan 2025
First submitted
9 Jan 2025
Last updated
15 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Tools in people with Suicide Prevention and Suicidal Ideation, run by University Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eva De Jaegere, PhD (+32 9 332.07.75, eva.dejaegere@ugent.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Co-creation questions (time frame: From enrolment to end of co-creation sessions (10 sessions of 1.5 hours max over the course of the study)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in